Clinical trials
Myopia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
193 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 11 |
| 2019 | 9 |
| 2020 | 18 |
| 2021 | 10 |
| 2022 | 23 |
| 2023 | 29 |
| 2024 | 18 |
| 2025 | 21 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Unknown status | 51 |
| Recruiting | 39 |
| Not yet recruiting | 18 |
| Active, not recruiting | 16 |
| Enrolling by invitation | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Eye Disease Prevention and Treatment Center | 31 |
| Tianjin Eye Hospital | 23 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 19 |
| Beijing Tongren Hospital | 14 |
| Sun Yat-sen University | 13 |
| The Hong Kong Polytechnic University | 12 |
| Beijing Airdoc Technology Co., Ltd. | 5 |
| Ruihua Wei | 5 |
| Wenzhou Medical University | 5 |
| He Eye Hospital | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myopia | 193 |
| Refractive Errors | 29 |
| Astigmatism | 9 |
| Myopia, Degenerative | 7 |
| Hyperopia | 6 |
| Eye Diseases | 5 |
| Cataract | 3 |
| Amblyopia | 2 |
| Lacerations | 2 |
| Presbyopia | 2 |
Trials
Showing 26 to 50 of 193. Each trial links to its page on Pharma Observatory.
93 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.